Skip to main content
SpringerLink
Log in

Improving Drug Safety — A Joint Responsibility

  • Conference proceedings
  • © 1991

Overview

Editors:
  1. Rolf Dinkel

    1. HealthEcon Ltd., Basel, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Bruno Horisberger

    1. Interdisciplinary Research Centre for Pulic Health, St. Gallen, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Kenneth W. Tolo

    1. The University of Texas at Austin, Austin, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Health Systems Research (HEALTH)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (59 papers)

  1. Front Matter

    Pages I-XXI
    Download chapter PDF

  2. The Wolfsberg Dialogue

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. From Questions to Missions and Actions

      • Rolf Dinkel, Bruno Horisberger, Kenneth W. Tolo
      Pages 3-4

    3. The RAD-AR Agenda

      • W. P. von Wartburg
      Pages 5-9

  3. Welcoming Addresses

    1. Front Matter

      Pages 11-11
      Download chapter PDF

    2. Council for International Organizations of Medical Sciences

      • Z. Bankowski
      Pages 13-14

    3. International Federation of Pharmaceutical Manufacturers Associations

      • R. B. Arnold
      Pages 15-16

    4. Intercantonal Office for the Control of Medicines

      • J. Pfanner
      Pages 17-18

    5. RAD-AR Consortium

      • P. Simon
      Pages 19-20

  4. Ethical Perspectives

    1. Front Matter

      Pages 21-21
      Download chapter PDF

    2. The Discipline of Ethics

      • S. Gorovitz
      Pages 23-26

    3. Ethics and Health

      • Z. Bankowski
      Pages 27-35

    4. Biomedical Ethical Perspective

      • E. W. D. Young
      Pages 36-46

    5. Corporate Ethics

      • K. M. Leisinger
      Pages 47-57

    6. Discussion

      • Rolf Dinkel, Bruno Horisberger, Kenneth W. Tolo
      Pages 58-61

  5. Generating Knowledge About Drug Risks

    1. Front Matter

      Pages 63-63
      Download chapter PDF

    2. Categories of Risk and Worldwide Resources

      • J. K. Jones
      Pages 65-74

    3. International Risk Assessment

      • K. Strandberg
      Pages 75-79

    4. Resources Needed for Risk Assessment

      • G. A. Faich
      Pages 80-85

  6. Generating Knowledge About Drug Benefits

    1. Front Matter

      Pages 87-87
      Download chapter PDF
Back to top

Keywords

About this book

As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety? In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an "international dialogue conference" by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica­ tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).

Editors and Affiliations

  • HealthEcon Ltd., Basel, Switzerland

    Rolf Dinkel

  • Interdisciplinary Research Centre for Pulic Health, St. Gallen, Switzerland

    Bruno Horisberger

  • The University of Texas at Austin, Austin, USA

    Kenneth W. Tolo

Bibliographic Information

  • Book Title: Improving Drug Safety — A Joint Responsibility

  • Editors: Rolf Dinkel, Bruno Horisberger, Kenneth W. Tolo

  • Series Title: Health Systems Research

  • DOI: https://doi.org/10.1007/978-3-642-61250-3

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1991

  • Softcover ISBN: 978-3-642-64762-8Published: 26 September 2011

  • eBook ISBN: 978-3-642-61250-3Published: 07 March 2013

  • Series ISSN: 1431-4002

  • Edition Number: 1

  • Number of Pages: XXI, 338

  • Topics: Pharmacology/Toxicology, Medicine/Public Health, general

Publish with us

Policies and ethics

Back to top

Search

Navigation